Xuedan Zhu

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Plasma thioredoxin reductase: a potential diagnostic biomarker for gastric cancer.

Plasma thioredoxin reductase: a potential diagnostic biomarker for gastric cancer.

Journal: Carcinogenesis

Published: April 07, 2022

Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway.

Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway.

Journal: Bioengineered

Published: February 24, 2022

The drugs screened by OncoVeeTM-Mini-PDX have significantly benefited the patient with HER2-positive advanced gastric cancer.

The drugs screened by OncoVeeTM-Mini-PDX have significantly benefited the patient with HER2-positive advanced gastric cancer.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: January 24, 2022

Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.

Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.

Journal: Bioengineered

Published: December 14, 2021

Progress and challenges of immunotherapy in triple-negative breast cancer.

Progress and challenges of immunotherapy in triple-negative breast cancer.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: May 16, 2021

HER2-targeted therapies in gastric cancer.

HER2-targeted therapies in gastric cancer.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: January 29, 2021

Circulating tumor cells: A surrogate to predict the effect of treatment and overall survival in gastric adenocarcinoma.

Circulating tumor cells: A surrogate to predict the effect of treatment and overall survival in gastric adenocarcinoma.

Journal: The International journal of biological markers

Published: January 27, 2021

The regulatory relationship and function of LncRNA FAM225A-miR-206-ADAM12 in gastric cancer.

The regulatory relationship and function of LncRNA FAM225A-miR-206-ADAM12 in gastric cancer.

Journal: American journal of translational research

Published: July 19, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026